#hydroaminoalkylation
Opening the conference #EuCOMC2025 @laurelschafer.bsky.social on the intricacies of #hydroaminoalkylation chemistry
July 6, 2025 at 3:05 PM
#NMRchat Branch-Selective Olefin Hydroaminoalkylation from Ti(III)–Al Bimetallic Intermediates Evidenced by EPR Hyperfine Spectroscopy and DFT Calculations http://dx.doi.org/10.1021/jacs.5c02920
May 1, 2025 at 12:08 PM
“Understanding mechanism driven regioselectivity in zirconium-catalysed hydroaminoalkylation: homoallylic amines from conjugated dienes” from Laurel L. Schafer et al.

doi.org/10.1039/D4SC...
Understanding mechanism driven regioselectivity in zirconium-catalysed hydroaminoalkylation: homoallylic amines from conjugated dienes
The unexpected 4,1-hydroaminoalkylation of dienes provides selective access to linear homoallylic amines by zirconium catalysis. This switch from the traditional branched preferred regioselectivity to selective linear product formation using this early transition metal can be attributed to π-allyl intermedia
doi.org
May 1, 2025 at 9:00 AM
Congrats to Max Thompson and team, who show that highly functionalized small molecules can be assembled using hydroaminoalkylation. Insights into catalyst and substrate control. A lesson in patience and persistence - his 1st paper, a 1st author JACS!! 🔥🔥 pubs.acs.org/doi/10.1021/...
Regioselective Hydroaminoalkylation with Silylated Alkenes for β-Amino Acid Synthesis
Catalyst and substrate steric and electronic features that influence regioselectivity in hydroaminoalkylation were leveraged to develop a synthetic approach for the selective synthesis of β-amino acids. An in situ generated tantalum-ureate catalyst was used to prepare 18 γ-silylated amines in up to 93% yield from internal silylated alkenes. β-Amino silane regioisomer production was rarely observed, making this work one of the few examples of highly regioselective hydroaminoalkylation with unsymmetric internal alkenes. These γ-amino silanes were converted to γ-amino alcohols with a modified Tamao–Fleming oxidation strategy followed by two additional steps to prepare β-amino acids, including a key fragment of the anticancer drug candidate Ipatasertib.
pubs.acs.org
April 9, 2025 at 1:28 PM